A review of the Ghana National Health Insurance Scheme claims database: possibilities and limits for drug utilization research: possibilities and limits for drug utilization research
Uložené v:
| Názov: | A review of the Ghana National Health Insurance Scheme claims database: possibilities and limits for drug utilization research: possibilities and limits for drug utilization research |
|---|---|
| Autori: | Macarius Donneyong, Francis Asenso-Boadi, Jesper Hallas, Lydia Dsane-Selby, Daniel Ankrah, James B. Odei |
| Zdroj: | Ankrah, D, Hallas, J, Odei, J, Asenso-Boadi, F, Dsane-Selby, L & Donneyong, M 2019, ' A review of the Ghana National Health Insurance Scheme claims database : possibilities and limits for drug utilization research ', Basic & Clinical Pharmacology & Toxicology, vol. 124, no. 1, pp. 18-27 . https://doi.org/10.1111/bcpt.13136 |
| Informácie o vydavateľovi: | Wiley, 2018. |
| Rok vydania: | 2018 |
| Predmety: | Drug Prescriptions/statistics & numerical data, Databases, Factual, National Health Programs, national health insurance scheme, claims database, drug utilization research, Databases, Factual/statistics & numerical data, Drug Prescriptions, Ghana, 3. Good health, Databases, Insurance Claim Review, 03 medical and health sciences, Drug Utilization Review, 0302 clinical medicine, Drug Utilization Review/methods, Insurance Claim Review/statistics & numerical data, Factual/statistics & numerical data, Humans, defined daily dose, National Health Programs/statistics & numerical data |
| Popis: | BackgroundThere are inadequate data on prescribed drug utilization in Sub‐Saharan Africa (SSA). Drug utilization research (DUR) in this region is hampered by lack of access to databases that capture prescribed drug utilization such as health insurance claims, electronic medical records and disease registries. The primary objective of this MiniReview was to describe the content of the NHIS claims database in the context of the health care system in Ghana. We will also review the possibilities and limitations of analysing this novel database for drug utilization research (DUR) in Ghana.MethodsWe reviewed the history, composition of the database, coverage and health systems in Ghana. To demonstrate the application of the NHIS claims database for DUR, we reviewed the NHIS’ drug formulary (NHIS medicines’ list), assessed and quantified the utilization of the top 25 most commonly prescribed medicines and their distributions by age, sex, region of residence and by MDCs.ResultsAs of December 2014, about 40% (~10.5 million) of the Ghanaian population were active beneficiaries of NHIS. There were 1.43 million unique patients in the NHIS claims database who received services from about 81 providers located in 9 out of the 10 regions in Ghana. The mean age of this sample of beneficiaries was 31 (standard deviation, 22) years, a third of whom were aged NHIS medicine list. Overall, analgesic was the most prescribed class of medicine (mostly paracetamol and diclofenac). Antimalarials, artemether‐lumefantrine, were observed as the second most prescribed medicines followed by anti‐infectives (metronidazole) and antihypertensives (amlodipine).ConclusionThe Ghana NHIS claims database is a great resource for DUR. This database could also be extended to facilitate pharmacoepidemiological and other health services’ research especially if transformed into one of the existing standardized common data models. |
| Druh dokumentu: | Article |
| Popis súboru: | application/pdf |
| Jazyk: | English |
| ISSN: | 1742-7843 1742-7835 |
| DOI: | 10.1111/bcpt.13136 |
| Prístupová URL adresa: | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.13136 https://pubmed.ncbi.nlm.nih.gov/30260590 https://pubmed.ncbi.nlm.nih.gov/30260590/ https://portal.findresearcher.sdu.dk/da/publications/a-review-of-the-ghana-national-health-insurance-schemeclaims-data https://europepmc.org/article/MED/30260590 https://onlinelibrary.wiley.com/doi/full/10.1111/bcpt.13136 https://findresearcher.sdu.dk:8443/ws/files/146416695/A_review_of_the_Ghana_National_Health_Insurance_Scheme_claims_database.pdf http://ugspace.ug.edu.gh/handle/123456789/30590 https://findresearcher.sdu.dk:8443/ws/files/146416695/A_review_of_the_Ghana_National_Health_Insurance_Scheme_claims_database.pdf |
| Rights: | Wiley Online Library User Agreement |
| Prístupové číslo: | edsair.doi.dedup.....c6cc9be64aeea52dbba2a6e2b1e9a7e7 |
| Databáza: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | BackgroundThere are inadequate data on prescribed drug utilization in Sub‐Saharan Africa (SSA). Drug utilization research (DUR) in this region is hampered by lack of access to databases that capture prescribed drug utilization such as health insurance claims, electronic medical records and disease registries. The primary objective of this MiniReview was to describe the content of the NHIS claims database in the context of the health care system in Ghana. We will also review the possibilities and limitations of analysing this novel database for drug utilization research (DUR) in Ghana.MethodsWe reviewed the history, composition of the database, coverage and health systems in Ghana. To demonstrate the application of the NHIS claims database for DUR, we reviewed the NHIS’ drug formulary (NHIS medicines’ list), assessed and quantified the utilization of the top 25 most commonly prescribed medicines and their distributions by age, sex, region of residence and by MDCs.ResultsAs of December 2014, about 40% (~10.5 million) of the Ghanaian population were active beneficiaries of NHIS. There were 1.43 million unique patients in the NHIS claims database who received services from about 81 providers located in 9 out of the 10 regions in Ghana. The mean age of this sample of beneficiaries was 31 (standard deviation, 22) years, a third of whom were aged NHIS medicine list. Overall, analgesic was the most prescribed class of medicine (mostly paracetamol and diclofenac). Antimalarials, artemether‐lumefantrine, were observed as the second most prescribed medicines followed by anti‐infectives (metronidazole) and antihypertensives (amlodipine).ConclusionThe Ghana NHIS claims database is a great resource for DUR. This database could also be extended to facilitate pharmacoepidemiological and other health services’ research especially if transformed into one of the existing standardized common data models. |
|---|---|
| ISSN: | 17427843 17427835 |
| DOI: | 10.1111/bcpt.13136 |